BioCentury
ARTICLE | Clinical News

Virulizin bovine bile extract: Phase I/II

July 22, 1996 7:00 AM UTC

Imutec Corp. (IMUTF), Toronto, Ontario Product: Virulizin bovine bile extract Indication: Kaposi's sarcoma resistant to drug treatment in AIDS Status: IMUTF began a Phase I/II trial in Canada to exam...